Clinical Study

A Randomized, Double-Blind, Placebo-Controlled Safety Study Of Ds-5565 For Treatment Of Pain Due To Fibromyalgia In Subjects With Chronic Kidney Disease.

Posted Date: Apr 7, 2017

  • Investigator: Lesley Arnold
  • Co-Investigator: Gayathri Pulapaka
  • Specialties:
  • Type of Study: Drug

The purpose of this study is to gather information and test the safety and tolerability of an investigational drug compared to a placebo (inactive substance) that may help treat pain caused by fibromyalgia in people with reduced kidney function.


Adults 18 Years Of Age And Older With Fibromyalgia And Reduced Kidney Function May Be Eligible To Participate


Kidney Disease, Fibromyalgia, Null, Null, Null

For More Information:

Kerri Earles

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.